We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Why Is MKS Instruments (MKSI) Down 1.3% Since Last Earnings Report?
Read MoreHide Full Article
A month has gone by since the last earnings report for MKS Instruments (MKSI - Free Report) . Shares have lost about 1.3% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is MKS Instruments due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers.
MKS Instruments Q2 Earnings Top Estimates, Revenues Down
MKS Instruments reported adjusted earnings of $1.53 per share in second-quarter 2024, up from the year-ago quarter’s earnings of $1.32 per share. The figure beat the Zacks Consensus Estimate by 50%.
Revenues of $887 million beat the consensus mark by 2.73% but declined 11.6% year over year.
Products revenues (86.8% of total revenues) were $770 million, down 13% year over year.
Services revenues (13.2% of total revenues) dropped 0.8% year over year to $117 million.
Quarterly Update
Revenues from the Semiconductor market (41.6% of total revenues) fell 16.3% year over year to $369 million. The figure beat the Zacks Consensus Estimate by 7.62%.
Electronics & Packaging revenues (25.8% of total revenues) were $229 million, higher than $225 million reported in the year-ago quarter. The figure beat the Zacks Consensus Estimate by 6.55%.
Specialty Industrial revenues (32.6% of total revenues) declined 14.2% year over year to $289 million. The figure missed the Zacks Consensus Estimate by 5.97%.
Operating Details
In the second quarter, the adjusted gross margin expanded 40 basis points (bps) on a year-over-year basis to 47.2%.
Research & development, as a percentage of revenues, was flat year over year. Sales, general & administrative expenses, as a percentage of revenues, contracted 100 bps on a year-over-year basis.
MKS Instruments reported a non-GAAP operating income of $192 million, down 15.4% year over year. The adjusted operating margin contracted 100 bps year over year to 21.6%.
Adjusted EBITDA was down 14% year over year to $228 million. Adjusted EBITDA margin fell 70 bps on a year-over-year basis to 25.7%.
Balance Sheet
As of Jun 30, 2024, MKS Instruments had cash and cash equivalents of $850 million compared with $845 million as of Mar 31, 2024.
Cash flow from operations was $122 million in second-quarter 2024 compared with the first-quarter 2024 figure of $67 million.
Free cash flow was $96 million compared with $49 million reported in the previous quarter.
In the second quarter, the company paid a cash dividend of $15 million or 22 cents per share.
Guidance
MKSI expects third-quarter 2024 revenues of $870 million (+/- $40 million).
The company expects an Adjusted EBITDA of $206 million (+/- 23 million).
On a non-GAAP basis, MKSI expects earnings of $1.43 (+/- 28 cents) per share.
How Have Estimates Been Moving Since Then?
It turns out, estimates review flatlined during the past month.
The consensus estimate has shifted 5.65% due to these changes.
VGM Scores
At this time, MKS Instruments has a poor Growth Score of F, however its Momentum Score is doing a lot better with an A. Charting a somewhat similar path, the stock was allocated a grade of B on the value side, putting it in the second quintile for this investment strategy.
Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
MKS Instruments has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Why Is MKS Instruments (MKSI) Down 1.3% Since Last Earnings Report?
A month has gone by since the last earnings report for MKS Instruments (MKSI - Free Report) . Shares have lost about 1.3% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is MKS Instruments due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers.
MKS Instruments Q2 Earnings Top Estimates, Revenues Down
MKS Instruments reported adjusted earnings of $1.53 per share in second-quarter 2024, up from the year-ago quarter’s earnings of $1.32 per share. The figure beat the Zacks Consensus Estimate by 50%.
Revenues of $887 million beat the consensus mark by 2.73% but declined 11.6% year over year.
Products revenues (86.8% of total revenues) were $770 million, down 13% year over year.
Services revenues (13.2% of total revenues) dropped 0.8% year over year to $117 million.
Quarterly Update
Revenues from the Semiconductor market (41.6% of total revenues) fell 16.3% year over year to $369 million. The figure beat the Zacks Consensus Estimate by 7.62%.
Electronics & Packaging revenues (25.8% of total revenues) were $229 million, higher than $225 million reported in the year-ago quarter. The figure beat the Zacks Consensus Estimate by 6.55%.
Specialty Industrial revenues (32.6% of total revenues) declined 14.2% year over year to $289 million. The figure missed the Zacks Consensus Estimate by 5.97%.
Operating Details
In the second quarter, the adjusted gross margin expanded 40 basis points (bps) on a year-over-year basis to 47.2%.
Research & development, as a percentage of revenues, was flat year over year. Sales, general & administrative expenses, as a percentage of revenues, contracted 100 bps on a year-over-year basis.
MKS Instruments reported a non-GAAP operating income of $192 million, down 15.4% year over year. The adjusted operating margin contracted 100 bps year over year to 21.6%.
Adjusted EBITDA was down 14% year over year to $228 million. Adjusted EBITDA margin fell 70 bps on a year-over-year basis to 25.7%.
Balance Sheet
As of Jun 30, 2024, MKS Instruments had cash and cash equivalents of $850 million compared with $845 million as of Mar 31, 2024.
Cash flow from operations was $122 million in second-quarter 2024 compared with the first-quarter 2024 figure of $67 million.
Free cash flow was $96 million compared with $49 million reported in the previous quarter.
In the second quarter, the company paid a cash dividend of $15 million or 22 cents per share.
Guidance
MKSI expects third-quarter 2024 revenues of $870 million (+/- $40 million).
The company expects an Adjusted EBITDA of $206 million (+/- 23 million).
On a non-GAAP basis, MKSI expects earnings of $1.43 (+/- 28 cents) per share.
How Have Estimates Been Moving Since Then?
It turns out, estimates review flatlined during the past month.
The consensus estimate has shifted 5.65% due to these changes.
VGM Scores
At this time, MKS Instruments has a poor Growth Score of F, however its Momentum Score is doing a lot better with an A. Charting a somewhat similar path, the stock was allocated a grade of B on the value side, putting it in the second quintile for this investment strategy.
Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
MKS Instruments has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.